Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary Care (PMT-ID)

August 26, 2026 updated by: Muhammet Faruk Yigit, Yuzuncu Yil University

The Effect of Protection Motivation Theory-Based Education on Infectious Disease Perception, Risk Awareness, and Protective Health Behaviors in Primary Care

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. The intervention group will receive a face-to-face educational program based on Protection Motivation Theory, while the control group will continue to receive routine health services without an additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4 using validated self-report measures.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is a controlled quasi-experimental study with a pretest-posttest design. It will be conducted among adults attending a primary care center. The study is designed to evaluate whether an educational intervention based on Protection Motivation Theory can improve participants' perceptions of infectious diseases, awareness of infectious disease risks, and protective health behaviors.

Participants will be allocated to an intervention group and a control group. Before the intervention, participants in both groups will complete baseline assessments. Participants in the intervention group will then receive a face-to-face educational program based on Protection Motivation Theory. The educational content will address routes of infectious disease transmission, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. Participants in the control group will not receive the educational intervention during the study period and will continue to receive routine health services.

At Week 4, participants in both groups will complete the post-intervention assessments. Changes in infectious disease perception, risk awareness, and protective health behaviors will be evaluated by comparing pre-intervention and post-intervention measurements between and within the groups.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being 18 years of age or older.
  • Being registered with and receiving services from the family health center where the study is conducted.
  • Being able to communicate in Turkish.
  • Voluntarily agreeing to participate in the study.
  • Being able to complete the study questionnaires and participate in the educational intervention.

Exclusion Criteria:

  • Having a condition that prevents effective communication or participation in the educational intervention.
  • Declining to participate or withdrawing consent at any stage of the study.
  • Failing to complete the required pre-intervention or post-intervention assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Protection Motivation Theory-Based Education Group
Participants in this arm will receive a face-to-face educational program based on Protection Motivation Theory. The program will address infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors.
Behavioral: Protection Motivation Theory-Based Educational Program
Participants in the intervention group will receive a face-to-face educational program based on Protection Motivation Theory. The program will cover infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. The intervention is designed to enhance threat appraisal and coping appraisal related to infectious disease prevention and to promote protective health behaviors.
No Intervention: Control Group
Participants in this arm will not receive the Protection Motivation Theory-based educational intervention during the study period and will continue to receive routine health services. They will complete the same pretest and posttest assessments as the intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Communicable Diseases Risk Awareness and Protection
Time Frame: Baseline and Week 4
Communicable disease risk awareness and protection will be assessed using the Communicable Diseases Risk Awareness and Protection Scale (CDRAPS). The scale consists of 36 items rated on a 5-point Likert scale, with total scores ranging from 36 to 180. Higher scores indicate higher levels of communicable disease risk awareness and protection. Change in total score from baseline to Week 4 will be evaluated.
Baseline and Week 4
Change in Perception Toward Infectious Diseases
Time Frame: Baseline and Week 4
Perception toward infectious diseases will be assessed using the Perception Scale for Infectious Diseases. The scale consists of 34 items rated on a 5-point Likert scale, with total scores ranging from 34 to 170. Higher scores indicate a more positive perception toward infectious diseases. Change in total score from baseline to Week 4 will be evaluated.
Baseline and Week 4
Change in Preventive Health Behaviors for Emerging Infectious Diseases
Time Frame: Baseline and Week 4
Preventive health behaviors will be assessed using the Turkish version of the Emerging Infectious Diseases Preventive Health Behavior Scale (EID-PHB-T-30). The scale consists of 30 items rated on a 5-point Likert scale, with total scores ranging from 30 to 150. Higher scores indicate higher levels of preventive health behaviors against emerging infectious diseases. Change in total score from baseline to Week 4 will be evaluated.
Baseline and Week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yuzuncu Yil University

Investigators

  • Principal Investigator: Muhammet Faruk Yigit, PhD, Yuzuncu Yil University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

October 5, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

August 23, 2026

First Submitted That Met QC Criteria

August 26, 2026

First Posted (Actual)

August 27, 2026

Study Record Updates

Last Update Posted (Actual)

August 27, 2026

Last Update Submitted That Met QC Criteria

August 26, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 16.06.2026-251887

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe